Svas Biosana S.p.A. (BIT:SVS)

Svas Biosana Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.18	24.05	33.4	34.25	21.63	30.44
Short-Term Investments	13.48	13.42	4	5.75	7.9	0.62
Cash & Short-Term Investments	29.66	37.47	37.39	40	29.53	31.06
Cash Growth	5.61%	0.21%	-6.53%	35.49%	-4.94%	330.33%
Accounts Receivable	53.86	51.14	46.08	41.37	39	31.83
Other Receivables	4.34	5.62	4.8	7.85	4.73	3.66
Receivables	58.2	56.76	50.88	49.21	43.73	35.49
Inventory	42.44	39.85	33.97	32.66	29.82	25.13
Total Current Assets	131.31	134.98	123.15	122.73	103.82	92.33
Property, Plant & Equipment	27.66	27.68	27.11	26.77	26.21	25.64
Long-Term Investments	0.12	0.1	0.17	0.17	0.29	0.22
Goodwill	5.94	6.13	0.4	0.68	0.96	1.05
Other Intangible Assets	11.69	11.76	11.11	9.88	8.77	7.97
Long-Term Deferred Tax Assets	-	-	0.01	0.01	-	-
Long-Term Deferred Charges	0.7	0.72	0.43	0.86	1.29	1.73
Other Long-Term Assets	3.87	3.52	3.17	4.5	4.89	6.95
Total Assets	181.3	184.91	165.55	165.6	146.23	135.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	33.11	32.43	28.85	31	28.2	23.34
Accrued Expenses	3.88	3.14	3.12	3.99	3.91	3.41
Current Portion of Long-Term Debt	37.24	35.18	27.5	27.28	22.88	21.23
Current Income Taxes Payable	0.06	0.06	0.07	0.11	0.17	0.05
Other Current Liabilities	3.27	3.33	2.78	2.42	2.17	1.68
Total Current Liabilities	77.56	74.15	62.31	64.81	57.33	49.7
Long-Term Debt	31.98	41.22	38.47	39.9	32.38	33.11
Other Long-Term Liabilities	2.07	2.01	1.92	1.9	2	2.11
Total Liabilities	111.61	117.38	102.7	106.61	91.72	84.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	20.6	20.6	20.6	20.6	20.6	20.6
Additional Paid-In Capital	18.18	18.18	18.18	18.18	18.18	18.18
Retained Earnings	32.44	30.09	24.65	20.36	15.27	11.75
Treasury Stock	-4.25	-4.03	-3.23	-2.92	-2.48	-2
Comprehensive Income & Other	2.59	2.55	2.63	2.77	2.93	2.43
Total Common Equity	69.56	67.39	62.83	58.98	54.5	50.96
Minority Interest	0.12	0.14	0.01	0.01	0.01	0
Shareholders' Equity	69.68	67.53	62.84	58.99	54.51	50.97
Total Liabilities & Equity	181.3	184.91	165.55	165.6	146.23	135.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	69.22	76.41	65.97	67.18	55.26	54.34
Net Cash (Debt)	-39.56	-38.93	-28.58	-27.18	-25.74	-23.28
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-7.44	-5.36	-	-4.75	-
Filing Date Shares Outstanding	-	5.22	5.31	-	5.41	-
Total Common Shares Outstanding	-	5.24	5.33	-	5.42	-
Working Capital	53.75	60.83	60.83	57.92	46.48	42.63
Book Value Per Share	-	12.87	11.79	-	10.06	-
Tangible Book Value	51.93	49.49	51.32	48.42	44.77	41.94
Tangible Book Value Per Share	-	9.45	9.63	-	8.26	-
Land	-	-	-	-	-	5.76
Machinery	-	-	-	-	-	52.17
Construction In Progress	-	-	-	-	-	3.05

Data Source: S&P Global Market Intelligence Last updated: Sep 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 13, 2026

Data Sources Report a data error